AU2003226907A8 - Method for the preparation of recombinant mammalian heparin-binding protein (hbp) - Google Patents

Method for the preparation of recombinant mammalian heparin-binding protein (hbp)

Info

Publication number
AU2003226907A8
AU2003226907A8 AU2003226907A AU2003226907A AU2003226907A8 AU 2003226907 A8 AU2003226907 A8 AU 2003226907A8 AU 2003226907 A AU2003226907 A AU 2003226907A AU 2003226907 A AU2003226907 A AU 2003226907A AU 2003226907 A8 AU2003226907 A8 AU 2003226907A8
Authority
AU
Australia
Prior art keywords
hbp
preparation
binding protein
recombinant mammalian
mammalian heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003226907A
Other versions
AU2003226907A1 (en
Inventor
Helle Fabricius Woldike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leukotech AS
Original Assignee
Leukotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leukotech AS filed Critical Leukotech AS
Publication of AU2003226907A1 publication Critical patent/AU2003226907A1/en
Publication of AU2003226907A8 publication Critical patent/AU2003226907A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
AU2003226907A 2002-03-27 2003-03-26 Method for the preparation of recombinant mammalian heparin-binding protein (hbp) Abandoned AU2003226907A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200200477 2002-03-27
DKPA200200477 2002-03-27
PCT/DK2003/000207 WO2003080660A2 (en) 2002-03-27 2003-03-26 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)

Publications (2)

Publication Number Publication Date
AU2003226907A1 AU2003226907A1 (en) 2003-10-08
AU2003226907A8 true AU2003226907A8 (en) 2003-10-08

Family

ID=28051662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226907A Abandoned AU2003226907A1 (en) 2002-03-27 2003-03-26 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)

Country Status (2)

Country Link
AU (1) AU2003226907A1 (en)
WO (1) WO2003080660A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2737065B1 (en) * 2011-07-29 2018-04-25 Georgia State University Research Foundation, Inc. Protein production method
CN108018294B (en) * 2018-01-02 2020-11-17 昆明理工大学 Panax notoginseng plant hormone binding protein genePnPhBP1And applications
CN117343200B (en) * 2023-12-04 2024-01-30 北京质肽生物医药科技有限公司 Fusion protein containing amyloid core polypeptide, preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617795B2 (en) * 1988-03-17 1991-12-05 Leukotech A/S Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
WO1999000417A1 (en) * 1997-06-25 1999-01-07 Novo Nordisk A/S Production of heparin-binding protein in mammalian cells
EP1032412A1 (en) * 1997-11-20 2000-09-06 Novo Nordisk A/S Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
AU4286100A (en) * 1999-04-29 2000-11-17 Leukotech A/S Expression of heparin-binding protein in recombinant mammalian cells

Also Published As

Publication number Publication date
WO2003080660A3 (en) 2003-12-18
AU2003226907A1 (en) 2003-10-08
WO2003080660A2 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
EP1490094A4 (en) Antibody fusion proteins: effective adjuvants of protein vaccination
AU2002249984A1 (en) Peptide or protein microassay method and apparatus
AUPR546801A0 (en) Recombinant antibodies
AU2003298523A8 (en) Methods for efficient production of mammalian recombinant proteins
AU2002364749A1 (en) Method for protein expression analysis
AU2002232803A1 (en) Expression system for recombinant proteins
AU2002251972A1 (en) Fusion proteins based upon somatostatin receptors
EP1366360A4 (en) Methods for large scale protein matching
AU2002224555A1 (en) Process for producing recombinant protein
AU7709000A (en) Methods for producing recombinant proteins
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
AU2003263161A8 (en) Method for making recombinant proteins
AU2001276916A1 (en) Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
AU2001244647A1 (en) Process for producing recombinant protein
AU2002311620A1 (en) Methods of making and using expression constructs for the expression of recombinant proteins
EP1434783A4 (en) Lp mammalian proteins; related reagents
PL377714A1 (en) Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods
AU2002342858A1 (en) Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
AU2003262638A8 (en) Biotinylation of proteins
AU2002361963A1 (en) Fusion proteins containing tlp peptides
AU2003295435A1 (en) Biological carriers for the delivery of proteins or peptides
AU2002344252A1 (en) Mammalian diabetes-mediating proteins
EP1608672A4 (en) Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
AU2003224295A8 (en) Protein stabilisation using chaperone proteins
AU2002356339A8 (en) Soluble recombinant protein production

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase